- Home
- BTAI vs BOF Comparison
BTAI vs BOF Comparison
Compare BTAI & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | BOF |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 43.4M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BTAI | BOF |
|---|---|---|
| Price | $1.80 | $3.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $26.67 | N/A |
| AVG Volume (30 Days) | ★ 644.4K | 40.4K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $752,000.00 | ★ $11,218,127.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $265.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 72.85 |
| 52 Week Low | $1.17 | $1.53 |
| 52 Week High | $8.08 | $3.66 |
Technical Indicators
Market Signals| Indicator | BTAI | BOF |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 47.72 |
| Support Level | $1.85 | $3.01 |
| Resistance Level | $2.08 | $3.46 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 38.57 | 32.96 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.